Development of Stabilized AAV Capsids for Vector Engineering

被引:0
|
作者
Pacouret, Simon [1 ]
Eid, Fatma Elzahraa [1 ]
Donahoe, William [1 ]
Chan, Ken Y. [1 ]
Wu, Jason [1 ]
Zheng, Qingxia [1 ]
Keyes, Casey [1 ]
Brauer, Pamela [1 ]
Chen, Albert [1 ]
Chan, Yujia A. [1 ]
Deverman, Benjamin [1 ]
机构
[1] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
44
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [41] NAVIGATE: A Directed Evolution Platform for Engineering Novel Ocular and Muscle AAV Capsids in Non-Human Primates
    Firnberg, Elad
    Tejada, Sigmund K. S.
    Yost, Samantha
    Giles, April R.
    Gaynutdinov, Timur
    Chen, Victor
    Foltz, Steven
    Elliot, Kirk
    Heithoff, Benjamin P.
    Smith, Jared B.
    Gumerson, Jessica
    Lilley, Brendan
    Karumuthil-Melethil, Subha
    Choi, Heonhwa
    Kaelber, Jason T.
    Danos, Olivier F.
    Mercer, Andrew C.
    Liu, Ye
    MOLECULAR THERAPY, 2024, 32 (04) : 266 - 267
  • [42] Incorporation of AAV Serotype 2 Viral Protein 2 into Other AAV Serotype Capsids
    Zhang, Daniel
    Li, Jun
    Feng, Yinglu
    Snowden, Adam
    Aslanidi, Georgy
    Muzyczka, Nicholas
    Srivastava, Arun
    Ling, Changquan
    Ling, Chen
    MOLECULAR THERAPY, 2016, 24 : S41 - S42
  • [43] Sequencing of Barcoded AAV Libraries Enables Reprogramming of AAV Capsids with Respect to Liver Tropism
    Zinn, Eric
    Schmit, Pauline
    Tipper, Christopher
    Sanmiguel, Julio
    Merkel, Erin
    Fieldsend, Allegra
    Diop, Cheikh
    Bhatt, Urja
    Franceschini, Jennifer Santos
    Estelien, Reynette
    Andres-Mateos, Eva
    Vandenberghe, Luk
    MOLECULAR THERAPY, 2020, 28 (04) : 14 - 14
  • [44] Engineering AAV Capsids with CNS-Targeted Biodistribution from Massively Diverse Libraries Using Machine Learning
    Packard, Thomas A.
    Cates, Erica
    Bazinet, Jeremy
    Stein, Kevin C.
    Jiang, Yue
    Lee, Michael
    Andrade, Maria F. L.
    Long, Thomas J.
    Huss, David J.
    Hause, Ron
    Briggs, Adrian W.
    MOLECULAR THERAPY, 2022, 30 (04) : 69 - 69
  • [45] AAV vector engineering for human aorta transduction: becoming a smooth operator
    Rapti, Kleopatra
    Grimm, Dirk
    GENE THERAPY, 2025,
  • [46] Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
    Gehrke, Miranda
    Diedrichs-Moehring, Maria
    Bogedein, Jacqueline
    Buning, Hildegard
    Michalakis, Stylianos
    Wildner, Gerhild
    CELLS, 2022, 11 (12)
  • [47] Incorporation of antigens into viral capsids augments efficacy of adeno-associated viral (AAV) vector-based vaccines
    Nowag, A.
    Rybniker, J.
    Janicki, H.
    Demant, K.
    Winter, S.
    Hartmann, P.
    Buening, H.
    HUMAN GENE THERAPY, 2012, 23 (10) : A40 - A40
  • [48] AAV(Lung)s: A Class of Lung Tropism AAV Capsids with Improved Specificity and Transduction Efficiency
    Wang, Bing
    Xu, Cheng
    Liu, Yu
    Wang, Yuyan
    Wang, Leming
    Shi, Zhen
    Yu, Daozhan
    Wang, Qizhao
    MOLECULAR THERAPY, 2024, 32 (04) : 692 - 692
  • [49] Developability Assessment of Novel AAV Capsids and Payloads at Early Preclinical Stage to Enable Development of Gene Therapies
    Placidi, Matteo P.
    Ramachandrareddy, Himabindu
    Vass, Robert
    Alvarez, David
    Dhanasekaran, Kumar
    MOLECULAR THERAPY, 2024, 32 (04) : 35 - 35
  • [50] Comparative study of liver gene therapy with AAV vectors based on endogenous and engineered AAV capsids
    Wang, L.
    Bell, P.
    Somanathan, S.
    Wang, Q.
    He, Z.
    Yu, H.
    McMenamin, D.
    Goode, T.
    Calcedo, R.
    Wilson, J. M.
    HUMAN GENE THERAPY, 2015, 26 (10) : A101 - A101